Learn More
Enzo Life Sciences BML-282 (5mg)

Supplier: Enzo Life Sciences BMLEI4000005
Novel inhibitor of ubiquitin C-terminal hydrolase L1 (IC50 = 0.81 µM). It displays 21-fold greater selectivity over UCH-L3 (IC50 = 17 µM). Alternative name: N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (5mg/ml with warming) or dimethyl formamide (10mg/ml with warming). Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.